Zacks: Brokerages Expect Cantel Medical Corp. (NYSE:CMD) to Announce $0.56 EPS
Brokerages predict that Cantel Medical Corp. (NYSE:CMD) will announce earnings per share of $0.56 for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cantel Medical’s earnings, with the lowest EPS estimate coming in at $0.55 and the highest estimate coming in at $0.56. Cantel Medical posted earnings of $0.62 per share in the same quarter last year, which indicates a negative year over year growth rate of 9.7%. The firm is expected to issue its next earnings report before the market opens on Tuesday, December 10th.
On average, analysts expect that Cantel Medical will report full-year earnings of $2.81 per share for the current year. For the next year, analysts forecast that the company will post earnings of $3.38 per share, with EPS estimates ranging from $3.34 to $3.41. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that follow Cantel Medical.
Cantel Medical (NYSE:CMD) last issued its quarterly earnings results on Monday, September 23rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.02. The business had revenue of $239.48 million during the quarter, compared to analyst estimates of $238.60 million. Cantel Medical had a return on equity of 15.34% and a net margin of 5.99%.
Cantel Medical Company Profile
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.